Clinical Trial

EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.

Study acronym: EU - ORCHID
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-27; most recent amendment 2026-03-04.
Status change: Not Yet Recruiting → Recruiting 2026-03-04
Trial Details
NCT Number NCT07006090
Lead Sponsor SamanTree Medical SA
Conditions Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® Scanner, Whatever the Disease Area
Enrollment 5,000 participants
Start Date 2026-03-04
Primary Completion 2036-03 (estimated)
Study Completion 2036-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-05